BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 36531494)

  • 1. Allosteric activation of preformed EGF receptor dimers by a single ligand binding event.
    Purba ER; Saita EI; Akhouri RR; Öfverstedt LG; Wilken G; Skoglund U; Maruyama IN
    Front Endocrinol (Lausanne); 2022; 13():1042787. PubMed ID: 36531494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of the EGF Receptor by Ligand Binding and Oncogenic Mutations: The "Rotation Model".
    Purba ER; Saita EI; Maruyama IN
    Cells; 2017 Jun; 6(2):. PubMed ID: 28574446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CR1/CR2 interactions modulate the functions of the cell surface epidermal growth factor receptor.
    Walker F; Orchard SG; Jorissen RN; Hall NE; Zhang HH; Hoyne PA; Adams TE; Johns TG; Ward C; Garrett TP; Zhu HJ; Nerrie M; Scott AM; Nice EC; Burgess AW
    J Biol Chem; 2004 May; 279(21):22387-98. PubMed ID: 15016810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of preformed EGF receptor dimers by ligand-induced rotation of the transmembrane domain.
    Moriki T; Maruyama H; Maruyama IN
    J Mol Biol; 2001 Aug; 311(5):1011-26. PubMed ID: 11531336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The tethering arm of the EGF receptor is required for negative cooperativity and signal transduction.
    Adak S; DeAndrade D; Pike LJ
    J Biol Chem; 2011 Jan; 286(2):1545-55. PubMed ID: 21047778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of the catalytic activity of the EGF receptor.
    Endres NF; Engel K; Das R; Kovacs E; Kuriyan J
    Curr Opin Struct Biol; 2011 Dec; 21(6):777-84. PubMed ID: 21868214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allosteric regulation of epidermal growth factor (EGF) receptor ligand binding by tyrosine kinase inhibitors.
    Macdonald-Obermann JL; Pike LJ
    J Biol Chem; 2018 Aug; 293(35):13401-13414. PubMed ID: 29997256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism for activation of the EGF receptor catalytic domain by the juxtamembrane segment.
    Jura N; Endres NF; Engel K; Deindl S; Das R; Lamers MH; Wemmer DE; Zhang X; Kuriyan J
    Cell; 2009 Jun; 137(7):1293-307. PubMed ID: 19563760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bipartite tetracysteine display reveals allosteric control of ligand-specific EGFR activation.
    Scheck RA; Lowder MA; Appelbaum JS; Schepartz A
    ACS Chem Biol; 2012 Aug; 7(8):1367-76. PubMed ID: 22667988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional and structural stability of the epidermal growth factor receptor in detergent micelles and phospholipid nanodiscs.
    Mi LZ; Grey MJ; Nishida N; Walz T; Lu C; Springer TA
    Biochemistry; 2008 Sep; 47(39):10314-23. PubMed ID: 18771282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging Allosteric Mechanism of EGFR Activation in Physiological and Pathological Contexts.
    Tsai CJ; Nussinov R
    Biophys J; 2019 Jul; 117(1):5-13. PubMed ID: 31202480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The ErbB/HER family of protein-tyrosine kinases and cancer.
    Roskoski R
    Pharmacol Res; 2014 Jan; 79():34-74. PubMed ID: 24269963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Membrane interaction of bound ligands contributes to the negative binding cooperativity of the EGF receptor.
    Arkhipov A; Shan Y; Kim ET; Shaw DE
    PLoS Comput Biol; 2014 Jul; 10(7):e1003742. PubMed ID: 25058506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ligand-induced dimer-tetramer transition during the activation of the cell surface epidermal growth factor receptor-A multidimensional microscopy analysis.
    Clayton AH; Walker F; Orchard SG; Henderson C; Fuchs D; Rothacker J; Nice EC; Burgess AW
    J Biol Chem; 2005 Aug; 280(34):30392-9. PubMed ID: 15994331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ligand regulation of a constitutively dimeric EGF receptor.
    Freed DM; Alvarado D; Lemmon MA
    Nat Commun; 2015 Jun; 6():7380. PubMed ID: 26060020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Architecture and membrane interactions of the EGF receptor.
    Arkhipov A; Shan Y; Das R; Endres NF; Eastwood MP; Wemmer DE; Kuriyan J; Shaw DE
    Cell; 2013 Jan; 152(3):557-69. PubMed ID: 23374350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular determinants of epidermal growth factor binding: a molecular dynamics study.
    Sanders JM; Wampole ME; Thakur ML; Wickstrom E
    PLoS One; 2013; 8(1):e54136. PubMed ID: 23382875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The membrane-proximal intracellular domain of the epidermal growth factor receptor underlies negative cooperativity in ligand binding.
    Adak S; Yang KS; Macdonald-Obermann J; Pike LJ
    J Biol Chem; 2011 Dec; 286(52):45146-55. PubMed ID: 22069315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The intracellular juxtamembrane domain of the epidermal growth factor (EGF) receptor is responsible for the allosteric regulation of EGF binding.
    Macdonald-Obermann JL; Pike LJ
    J Biol Chem; 2009 May; 284(20):13570-13576. PubMed ID: 19336395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural basis for negative cooperativity in growth factor binding to an EGF receptor.
    Alvarado D; Klein DE; Lemmon MA
    Cell; 2010 Aug; 142(4):568-79. PubMed ID: 20723758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.